STAB logo

Statera Biopharma (STAB) EBIT

Annual EBIT

-$30.74 M
-$19.72 M-178.78%

December 31, 2021


Summary


Performance

STAB EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSTABprofitabilitymetrics:

Quarterly EBIT

-$1.55 M
+$1.31 M+45.81%

September 30, 2022


Summary


Performance

STAB Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSTABprofitabilitymetrics:

TTM EBIT

-$19.17 M
+$8.10 M+29.70%

September 30, 2022


Summary


Performance

STAB TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSTABprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

STAB EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-178.8%+84.0%+24.9%
3 y3 years-992.4%-152.7%-3032.8%
5 y5 years-992.4%-152.7%-3032.8%

STAB EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high+81.0%at high+37.6%
5 y5-year-992.4%at low-152.7%+84.0%-3032.8%+37.6%
alltimeall time-992.4%at low-152.7%+84.0%-3032.8%+37.6%

Statera Biopharma EBIT History

DateAnnualQuarterlyTTM
Sep 2022
-
-$1.55 M(-45.8%)
-$19.17 M(-29.7%)
Jun 2022
-
-$2.85 M(-56.9%)
-$27.27 M(-11.3%)
Mar 2022
-
-$6.61 M(-18.9%)
-$30.74 M(+4.8%)
Dec 2021
-$30.74 M
-$8.16 M(-15.4%)
-$29.32 M(+14.9%)
Sep 2021
-
-$9.64 M(+52.5%)
-$25.51 M(+16.9%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$6.32 M(+21.7%)
-$21.82 M(+40.8%)
Mar 2021
-
-$5.19 M(+19.3%)
-$15.49 M(+42.0%)
Dec 2020
-$11.03 M(+291.9%)
-$4.35 M(-26.8%)
-$10.91 M(+66.4%)
Sep 2020
-
-$5.95 M(+871.9%)
-$6.56 M(+971.9%)
Mar 2020
-
-$611.90 K
-$611.90 K
Dec 2019
-$2.81 M
-
-

FAQ

  • What is Statera Biopharma annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Statera Biopharma?
  • What is Statera Biopharma annual EBIT year-on-year change?
  • What is Statera Biopharma quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Statera Biopharma?
  • What is Statera Biopharma quarterly EBIT year-on-year change?
  • What is Statera Biopharma TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Statera Biopharma?
  • What is Statera Biopharma TTM EBIT year-on-year change?

What is Statera Biopharma annual earnings before interest & taxes?

The current annual EBIT of STAB is -$30.74 M

What is the all time high annual EBIT for Statera Biopharma?

Statera Biopharma all-time high annual earnings before interest & taxes is -$2.81 M

What is Statera Biopharma annual EBIT year-on-year change?

Over the past year, STAB annual earnings before interest & taxes has changed by -$19.72 M (-178.78%)

What is Statera Biopharma quarterly earnings before interest & taxes?

The current quarterly EBIT of STAB is -$1.55 M

What is the all time high quarterly EBIT for Statera Biopharma?

Statera Biopharma all-time high quarterly earnings before interest & taxes is -$611.90 K

What is Statera Biopharma quarterly EBIT year-on-year change?

Over the past year, STAB quarterly earnings before interest & taxes has changed by +$8.10 M (+83.97%)

What is Statera Biopharma TTM earnings before interest & taxes?

The current TTM EBIT of STAB is -$19.17 M

What is the all time high TTM EBIT for Statera Biopharma?

Statera Biopharma all-time high TTM earnings before interest & taxes is -$611.90 K

What is Statera Biopharma TTM EBIT year-on-year change?

Over the past year, STAB TTM earnings before interest & taxes has changed by +$6.35 M (+24.87%)